Back to Trades
Nasus Pharma Ltd
NSRXCIK: 0002029039
Follow NSRX
Track Nasus Pharma Ltd insider trades on your dashboard. Email alerts with a subscription.
Nasus Pharma Ltd (NSRX) has recorded 11 insider filings from 8 unique insiders, totaling $61.8K in trading activity (net buying). Insiders have purchased $61.8K and sold $0, reflecting a net buying posture that may signal internal confidence in the company's near-term prospects. The most active insider by volume is Teleman Dan Benjamin. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.
Total Volume
$61.8K
Purchases
$61.8K
Sales
$0
Unique Insiders
8
Recent Insider Trades
11 loaded
| Jun 22 | NSRX Nasus Pharma Ltd | Teleman Dan Benjamin | Chief Executive Officer, Director | Buy | $20.3K |
| Apr 22 | NSRX Nasus Pharma Ltd | Teleman Dan Benjamin | Chief Executive Officer, Director | Buy | $10.9K |
| Apr 1 | NSRX Nasus Pharma Ltd | Teleman Dan Benjamin | Chief Executive Officer, Director | Buy | $30.6K |
| Mar 27 | NSRX Nasus Pharma Ltd | Silberman David | Director | Other | $0 |
| Mar 27 | NSRX Nasus Pharma Ltd | Israel Isaac | Director | Other | $0 |
| Mar 27 | NSRX Nasus Pharma Ltd | Shacham Sharon | Director | Other | $0 |
| Mar 27 | NSRX Nasus Pharma Ltd | Gilboa Udi | Insider | Other | $0 |
| Mar 27 | NSRX Nasus Pharma Ltd | Megiddo Dalia | Chief Development Officer, Director | Other | $0 |
| Mar 27 | NSRX Nasus Pharma Ltd | Hershman Ronnie | Director | Other | $0 |
| Mar 27 | NSRX Nasus Pharma Ltd | Teleman Dan Benjamin | Chief Executive Officer, Director | Other | $0 |
| Mar 27 | NSRX Nasus Pharma Ltd | Rubin Eyal | Chief Financial Officer | Other | $0 |
11 filings